Literature DB >> 19442330

The role of the sympathetic nervous system in obesity-related hypertension.

Alexandre A da Silva1, Jussara do Carmo, John Dubinion, John E Hall.   

Abstract

Obesity is recognized as a major health problem throughout the world. Excess weight is a major cause of increased blood pressure in most patients with essential hypertension and greatly increases the risk for diabetes, cardiovascular diseases, and end-stage renal disease. Although the mechanisms by which obesity raises blood pressure are not completely understood, increased renal sodium reabsorption, impaired pressure natriuresis, and volume expansion appear to play important roles. Several potential mechanisms have been suggested to contribute to altered kidney function and hypertension in obesity, including activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system, as well as physical compression of the kidneys, especially when visceral obesity is present. Activation of the sympathetic nervous system in obesity may be due, in part, to hyperleptinemia and other factors secreted by adipocytes and the gastrointestinal tract, activation of the central nervous system melanocortin pathway, and baroreceptor dysfunction.

Entities:  

Mesh:

Year:  2009        PMID: 19442330      PMCID: PMC2814329          DOI: 10.1007/s11906-009-0036-3

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN: 1522-6417            Impact factor:   5.369


  48 in total

Review 1.  Central nervous system control of food intake.

Authors:  M W Schwartz; S C Woods; D Porte; R J Seeley; D G Baskin
Journal:  Nature       Date:  2000-04-06       Impact factor: 49.962

Review 2.  Should we target the sympathetic nervous system in the treatment of obesity-associated hypertension?

Authors:  Italo Biaggioni
Journal:  Hypertension       Date:  2007-12-17       Impact factor: 10.190

Review 3.  Role of sympathetic nervous system and neuropeptides in obesity hypertension.

Authors:  J E Hall; M W Brands; D A Hildebrandt; J Kuo; S Fitzgerald
Journal:  Braz J Med Biol Res       Date:  2000-06       Impact factor: 2.590

4.  Involvement of nitric oxide in endothelium-dependent arterial relaxation by leptin.

Authors:  K Kimura; K Tsuda; A Baba; T Kawabe; S Boh-oka; M Ibata; C Moriwaki; T Hano; I Nishio
Journal:  Biochem Biophys Res Commun       Date:  2000-07-05       Impact factor: 3.575

5.  Baroreflexes prevent neurally induced sodium retention in angiotensin hypertension.

Authors:  T E Lohmeier; J R Lohmeier; A Haque; D A Hildebrandt
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2000-10       Impact factor: 3.619

6.  Molecular mechanisms of ghrelin-mediated endothelial nitric oxide synthase activation.

Authors:  Xiangbin Xu; Bong Sook Jhun; Chang Hoon Ha; Zheng-Gen Jin
Journal:  Endocrinology       Date:  2008-05-01       Impact factor: 4.736

7.  Endogenous melanocortin system activity contributes to the elevated arterial pressure in spontaneously hypertensive rats.

Authors:  Alexandre A da Silva; Jussara M do Carmo; Bela Kanyicska; John Dubinion; Elizabeth Brandon; John E Hall
Journal:  Hypertension       Date:  2008-02-19       Impact factor: 10.190

8.  Comparison of strategies for sustaining weight loss: the weight loss maintenance randomized controlled trial.

Authors:  Laura P Svetkey; Victor J Stevens; Phillip J Brantley; Lawrence J Appel; Jack F Hollis; Catherine M Loria; William M Vollmer; Christina M Gullion; Kristine Funk; Patti Smith; Carmen Samuel-Hodge; Valerie Myers; Lillian F Lien; Daniel Laferriere; Betty Kennedy; Gerald J Jerome; Fran Heinith; David W Harsha; Pamela Evans; Thomas P Erlinger; Arline T Dalcin; Janelle Coughlin; Jeanne Charleston; Catherine M Champagne; Alan Bauck; Jamy D Ard; Kathleen Aicher
Journal:  JAMA       Date:  2008-03-12       Impact factor: 56.272

Review 9.  Sympathetic nervous system behavior in human obesity.

Authors:  Kevin P Davy; Jeb S Orr
Journal:  Neurosci Biobehav Rev       Date:  2008-05-28       Impact factor: 8.989

10.  Modulation of blood pressure by central melanocortinergic pathways.

Authors:  Jerry R Greenfield; Jeffrey W Miller; Julia M Keogh; Elana Henning; Julie H Satterwhite; Gregory S Cameron; Beatrice Astruc; John P Mayer; Soren Brage; Teik Choon See; David J Lomas; Stephen O'Rahilly; I Sadaf Farooqi
Journal:  N Engl J Med       Date:  2008-12-17       Impact factor: 91.245

View more
  48 in total

1.  Does our fat tell our brain what to do? A sympathetic' appraisal.

Authors:  Gregory D Fink
Journal:  J Physiol       Date:  2010-05-01       Impact factor: 5.182

2.  Comments on Point:Counterpoint: The dominant contributor to systemic hypertension: Chronic activation of the sympathetic nervous system vs. Activation of the intrarenal renin-angiotensin system. Activated intrarenal renin-angiotensin system is correlated with high blood pressure in humans.

Authors:  Hiroyuki Kobori; Qi Fu; Steven D Crowley; Romer A Gonzalez-Villalobos; Ruy R Campos
Journal:  J Appl Physiol (1985)       Date:  2010-12

Review 3.  Obesity-induced hypertension: role of sympathetic nervous system, leptin, and melanocortins.

Authors:  John E Hall; Alexandre A da Silva; Jussara M do Carmo; John Dubinion; Shereen Hamza; Shankar Munusamy; Grant Smith; David E Stec
Journal:  J Biol Chem       Date:  2010-03-26       Impact factor: 5.157

4.  Peripheral vascular atherosclerosis in a novel PCSK9 gain-of-function mutant Ossabaw miniature pig model.

Authors:  Ahmad F Hedayat; Kyoung-Ha Park; Taek-Geun Kwon; John R Woollard; Kai Jiang; Daniel F Carlson; Amir Lerman; Lilach O Lerman
Journal:  Transl Res       Date:  2017-11-03       Impact factor: 7.012

Review 5.  Central nervous system dysfunction in obesity-induced hypertension.

Authors:  Geoffrey A Head; Kyungjoon Lim; Benjamin Barzel; Sandra L Burke; Pamela J Davern
Journal:  Curr Hypertens Rep       Date:  2014-09       Impact factor: 5.369

6.  Obesity-associated extracellular mtDNA activates central TGFβ pathway to cause blood pressure increase.

Authors:  Albert Alé; Yalin Zhang; Cheng Han; Dongsheng Cai
Journal:  Am J Physiol Endocrinol Metab       Date:  2016-11-15       Impact factor: 4.310

7.  The effect of a multidisciplinary weight loss program on renal circadian rhythm in obese adolescents.

Authors:  Kim Pauwaert; Sarah Dejonckheere; Elke Bruneel; Jolien Van Der Jeugt; Laura Keersmaekers; Saskia Roggeman; Ann De Guchtenaere; Johan Vande Walle; Karel Everaert
Journal:  Eur J Pediatr       Date:  2019-09-05       Impact factor: 3.183

8.  Adrenal cell aldosterone production is stimulated by very-low-density lipoprotein (VLDL).

Authors:  Yewei Xing; William E Rainey; John W Apolzan; Omar L Francone; Ruth B S Harris; Wendy B Bollag
Journal:  Endocrinology       Date:  2011-12-20       Impact factor: 4.736

Review 9.  Role of leptin and central nervous system melanocortins in obesity hypertension.

Authors:  Alexandre A da Silva; Jussara M do Carmo; John E Hall
Journal:  Curr Opin Nephrol Hypertens       Date:  2013-03       Impact factor: 2.894

10.  Soluble Prorenin Receptor Increases Blood Pressure in High Fat-Fed Male Mice.

Authors:  Eva Gatineau; Ming C Gong; Frédérique Yiannikouris
Journal:  Hypertension       Date:  2019-08-05       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.